The growth of this market is primarily driven by the growth of the pharmaceutical and biopharmaceutical industry, increasing demand for single-use technologies, and the advancements in nanofiltration techniques.
The global Pharmaceutical
Membrane Filtration Market is
valued at an estimated USD 5.1 billion in 2019 and is projected to reach USD
8.6 billion by 2024, growing at a CAGR of 11.0% during the forecast period.
Download
PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
Market Segmentation:-
On the basis of product, the pharmaceutical membrane
filtration market is segmented into filters, systems, and accessories. Filters
formed the largest product segment in this market owing to the high and growing
use of different types of membrane filters for various filtration applications
in the biopharmaceutical manufacturing industry.
On the basis of application, the Micro Filtration market is
segmented into final product processing, raw material filtration, cell
separation, water purification, and air purification. Final product processing
was the largest application segment in the pharmaceutical membrane filtration
market in 2018.
Regional
Analysis:-
The global pharmaceutical membrane filtration market is
segmented into North America, Europe, the Asia Pacific, and the Rest of the
World. In 2018, North America was the largest market for Micro Filtration
market, followed by Europe.
Recent Developments:-
- In 2018, Pall Corporation opened a center of
excellence for training on sterilization techniques, filtration, and cell
culture platforms.
- In 2018, GE Healthcare and the Swedish
Government opened an innovation center—Testa Center—in Sweden to support
the commercialization of advanced biopharmaceuticals.
- In 2016, Sartorius Stedim Biotech opened
its production and R&D facility in England.
Speak
to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255408031
Key
Market Players:-
The major companies operating in the pharmaceutical membrane
filtration market include Merck Millipore (Germany), Danaher (US) and Sartorius
Stedim Biotech (France).
No comments:
Post a Comment